NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: M
Post# of 174
(Total Views: 208)
Posted On: 10/02/2020 5:52:12 PM
NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) CEO Discusses Strategic Business Models, Nascent Stage of B2C Platform
Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, showcased its powerful capabilities during a recent virtual investor summit. Trxade Group’s CEO Suren Ajjarapu presented for the company to discuss the platform, which thrives on its business-to-business (“B2B”) model to provide radical transparency for drug pricing and availability while taking advantage of telehealth-friendly insurer policy shifts under its business-to-consumer (“B2C”) model. During his presentation, Ajjarapu highlighted comprehensive capabilities of the platform, including the vitality of its Bonum Health Hub portal-led B2C operations, serving approximately 15 million patients through the medium of over 11,700 independent pharmacies in its subscription network. An article discussing this includes commentary from Ajjarapu’s presentation, stating, “Of course our B2C platform is at a nascent stage when compared to other telemedicine portals out there, but with the unique nature of same-day drug delivery using our network. Our vision there is, for non-emergency services or health needs, patients should never leave the house and should be able to talk to the doctor, get the drugs or meds delivered directly to their home or office.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, showcased its powerful capabilities during a recent virtual investor summit. Trxade Group’s CEO Suren Ajjarapu presented for the company to discuss the platform, which thrives on its business-to-business (“B2B”) model to provide radical transparency for drug pricing and availability while taking advantage of telehealth-friendly insurer policy shifts under its business-to-consumer (“B2C”) model. During his presentation, Ajjarapu highlighted comprehensive capabilities of the platform, including the vitality of its Bonum Health Hub portal-led B2C operations, serving approximately 15 million patients through the medium of over 11,700 independent pharmacies in its subscription network. An article discussing this includes commentary from Ajjarapu’s presentation, stating, “Of course our B2C platform is at a nascent stage when compared to other telemedicine portals out there, but with the unique nature of same-day drug delivery using our network. Our vision there is, for non-emergency services or health needs, patients should never leave the house and should be able to talk to the doctor, get the drugs or meds delivered directly to their home or office.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Scienture Holdings, Inc. (SCNX) Stock Research Links
Scroll down for more posts ▼